Tamura Shinsuke, Maeda Takuya, Misawa Kazuhisa, Osa Morichika, Hamamoto Takaaki, Yuki Atsushi, Imai Kazuo, Mikita Kei, Morichika Kyoko, Kawana Akihiko, Matsumoto Hiroshi, Nonoyama Shigeaki
Department of Pediatrics, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan.
Division of Infectious Diseases and Pulmonary Medicine, Department of Internal Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan; Department of Microbiology, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan; Center for Clinical Infectious Diseases and Research, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
J Microbiol Methods. 2017 Oct;141:108-114. doi: 10.1016/j.mimet.2017.08.008. Epub 2017 Aug 12.
Rapid and easy detection of sequence polymorphisms, including nucleotide point mutations of bacterial pathogens responsible for amino acid substitutions linked to drug resistance, is essential for the proper use of antimicrobial agents. Here, a detection method using loop-mediated amplification (LAMP) combined with amplification refractory mutation system (ARMS) to accurately distinguish a different single nucleotide in the target sequence was established, named ARMS-SNP LAMP. This procedure is capable of species-specific detection of a nucleotide (1578T) in the ftsI gene on Haemophilus influenzae without amplifying the sequence carrying the point mutations (T1578G/A) in β-lactamase-negative ampicillin resistant (BLNAR) strains. Reactions were performed at 61°C for 45min. Successful target gene amplifications were detected by measuring real-time turbidity using a turbidimeter and visual detection. The assay had a detection limit of 10.0pg of genomic DNA per reaction and showed specificity against 52 types of pathogens, whereas amplifications were completely blocked in even 100.0ng/μL of genomic DNA with point mutations at T1578G and T1578A. The expected ARMS-SNP LAMP products were confirmed through identical melting curves in real-time LAMP procedures. This novel procedure was also used to analyze 57 clinical isolates of H. influenzae. All 25 clinical isolates with the naïve sequence of 1578T gave positive results. In addition, concordant negative results were obtained for 31 of the BLNAR strains with the T1578G mutation and one strain with the T1578A mutation. The ARMS-SNP LAMP method is a simple and rapid method for SNP-genotyping of a clinical isolate as point-of-care testing (POCT) technology. It is suitable for use in both resource-limited situations and well-equipped clinical settings because of its simplicity and convenience.
快速、简便地检测序列多态性,包括负责与耐药性相关氨基酸替代的细菌病原体的核苷酸点突变,对于抗菌药物的合理使用至关重要。在此,建立了一种使用环介导等温扩增(LAMP)结合扩增阻滞突变系统(ARMS)来准确区分靶序列中不同单核苷酸的检测方法,命名为ARMS-SNP LAMP。该方法能够对流感嗜血杆菌ftsI基因中的核苷酸(1578T)进行种特异性检测,而不会扩增β-内酰胺酶阴性氨苄西林耐药(BLNAR)菌株中携带点突变(T1578G/A)的序列。反应在61°C下进行45分钟。通过使用浊度仪测量实时浊度和视觉检测来检测成功的靶基因扩增。该检测方法的检测限为每个反应10.0 pg基因组DNA,对52种病原体具有特异性,而在T1578G和T1578A处有100.0 ng/μL点突变的基因组DNA中扩增完全受阻。通过实时LAMP程序中的相同熔解曲线确认了预期的ARMS-SNP LAMP产物。该新方法还用于分析57株流感嗜血杆菌临床分离株。所有25株具有1578T原始序列的临床分离株均给出阳性结果。此外,31株具有T1578G突变的BLNAR菌株和1株具有T1578A突变的菌株均获得一致的阴性结果。ARMS-SNP LAMP方法是一种简单快速的临床分离株单核苷酸多态性基因分型方法,可作为即时检验(POCT)技术。由于其简单方便,适用于资源有限的情况和设备完善的临床环境。